| |
Treatment cost(a)(b)
|
Difference(b)
|
|---|
| |
No program
|
Program
|
Absolute
|
%
|
| |
£8,325
|
£7,708
|
-£617
|
-7.4
|
| |
(£7,076 – £9,574)
|
(£6,444 – £8,972)
|
(-£2,394 – +£1,160)
| |
| |
Health outcome(c)
|
Difference(c)
|
| |
No program
|
Program
|
Absolute
|
%
|
|
Life-years
|
10.89
|
11.25
|
0.36
|
3.3
|
| |
(10.52 – 11.26)
|
(10.87 – 11.63)
|
(-0.17 – +0.89)
| |
|
QALE
|
8.25
|
8.54
|
0.30
|
3.6
|
| |
(7.98 – 8.51)
|
(8.27 – 8.81)
|
(-0.08 – +0.68)
| |
- (a) Treatment cost for diabetes-related complications from the UKPDS model using clinical data from the Australian patient sample
- (b) 95% confidence intervals in parentheses. Confidence interval for difference calculated as though independent estimates. These costs are health care costs associated with diabetes-related complications. They do not include ongoing care costs other than for complications. Costs reflect health care utilisation in the UK in the year 2000. Discount rate = 5% per annum
- (c) 95% confidence intervals in parentheses. Confidence interval for difference calculated as though independent estimates. Discount rate = 5% per annum.
-
Source: SHDGP Diabetes Program; UKPDS Outcomes Model [26]
